期刊文献+

bcr/abl反义寡聚脱氧核苷酸抑制慢性粒细胞白血病细胞生长的研究

Inhibitory effects of bcr/abl antisense oligodeoxynucleotide on chronic myelocytic leukemic cell growth
下载PDF
导出
摘要 目的:研究bcr/ abl基因的反义寡聚脱氧核苷酸(antisense oligodeoxynucleotide,ASON)对K5 6 2细胞生长的影响。方法:根据bcr/ abl基因类型(b3/ a2 )的c DNA序列分析,以其m RNA融合区的18个核苷酸为作用靶序列,人工合成了18聚ASON片段,同时合成18聚无义ASON片段,作为序列特异性对照。用ASON和无义ASON片段与K5 6 2细胞共同培养,同时设置空白对照组,作用一定时间后分别测定细胞动力学、3H- Td R掺入率、bcr/ abl m RNA和P2 10蛋白的表达。结果:3.5~30 .0 μmol·L- 1的ASON对K5 6 2细胞生长有不同程度的抑制作用,ASON浓度低于10 .0 μmol·L- 1时抑制作用很小,大于10 .0 μm ol·L- 1时抑制作用显著,这种作用有浓度、时间依赖关系,而无义ASON与空白对照组比较差异无显著性(P<0 .0 5 )。同时发现ASON使细胞的3H - Td R掺入率下降,bcr/ abl m RNA及P2 10蛋白的表达下降。结论:ASON的抑制作用是从基因水平上封闭了bcr/ abl m RNA转录及P2 10蛋白的翻译,抑制细胞的增殖,促进细胞凋亡。ASON对慢性粒细胞白血病(CML )细胞有抑制作用。 Objective To study the effects of bcr/abl antisense oligodeoxynucleotide (ASON) on K562 cell growth. Methods Eighteen nucleotides were used as target genes in bcr/abl mRNA mixed area, by different bcr/abl cDNA sequence type analysis, 18 pdy ASON fragments and 18 poly non-sense ASON fragments for special sequence control were synthesized. Incubating K562 cells with ASON or non-sense ASON fragments for a mean time, while a blank control was set up. Cytomorphology, the 3H-TdR mixed rate and the expressions of bcr/abl mRNA and P210 protein were detected. Results ASON had different inhibitory rates on cell proliferation at 3.5- 30.0 μmol·L -1 . The action was smaller when ASON concentration was less than 10.0 μmol·L -1 . While the action was more significant when the concentration was larger than 10.0 μmol·L -1 . This action depends on concentration and time. But non-sense ASON and control weren′t distinct different. At the meantime, ASON made the 3H-TdR mixed rate decrease and the expression levels of bcr/abl and P210 were down-regulated. Conclusion These results show that ASON hinders bcr/abl mRNA transcription and P210 protein translation, inhibits cell proliferation and promotes apoptosis on gene levels.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2005年第3期390-394,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅资助课题 (2 0 0 30 4 2 7- 0 3)
关键词 白血病 髓样 慢性 融合蛋白质类 bcr—abl 脱氧腺苷类 细胞凋亡 leukemia, myeloid, chronic fusion proteins, bcr-abl deoxyadenosines apoptosis
  • 相关文献

参考文献7

  • 1袁长吉,迟宝荣,姚程,易永林.RT-PCR方法检测慢性粒细胞白血病bcr/abl融合基因类型[J].吉林大学学报(医学版),2004,30(5):750-752. 被引量:9
  • 2McGahon A, Bissonnette R, Schimitt M, et al. BCR-ABL maintains resistence of chronic myelogenous leukemia cells to apoptotic cell death [J] . Blood, 1994, 83: 1179-1187.
  • 3Shtivelman E, Gale EP, Dreazen O, et al. bcr-abl RNA in patients with chronic myelogenous leukemia [J]. Blood, 1987,69: 971-973.
  • 4Shaw JP, Kent K, Bird J, et al. Modified deoxyoligonucleotides stable to exonuclease degradation in serum [J]. Nucleic Acids Res, 1991, 19: 747-750.
  • 5Goodchild J. Conjugates of oligonucleotide and modified oligonueleotides: a review of their synthesis and properties[J]. Bioeonjug Chem, 1990, 1(3): 165-187.
  • 6Macdonald RJ, Swift GH, Przybyla AE, et al. Isolation of RNA using guanidinium salts [J]. Methods Enzymol, 1987,219-227.
  • 7Collins SJ, Ruscetti FW, Gallagher RE, et al. Nrmal functionnal characteristics of cultured human promyeloyc leukemia cell (HL-60) after induction of differentiation by dimethylsulfoxide [J]. J Exp Med, 1977, 149: 969-974.

二级参考文献6

  • 1[1]Carrasco M, Sureda A , Martinez C,et al. Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients[J]. Ann Hematol, 2002, 81(12):710-716.
  • 2[2]Guo JQ, Lian JY, Xian YM, et al. bcr/abl protein expression in periperal blood cells of chronic myelogenous leukemia patients undergoing therapy[J]. Blood, 1994,83:3629-3637.
  • 3[3]McGahon A , Bissonnette R, Schimitt M , et al . bcr-abl maintains resistence of chronic myelogenous leukemia cells to apoptotic cell death[J]. Blood, 1994, 83 :1179-1187.
  • 4[5]Wang L, Pearson K, Pillitteri L, et al. Serial monitoring of bcr-abl by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia[J]. Br J Haematol, 2002,118(3):771-777.
  • 5[6]Martiat P, Michaux JL, Rodhain J. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Francais de Cytogenetique Hematologique[J]. Blood, 1991, 78: 205-211.
  • 6袁长吉,王建伟,李舜华,易永林.双标记原位杂交法检测间期细胞BCR/ABL融合基因[J].吉林大学学报(医学版),2003,29(5):637-639. 被引量:5

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部